Publication | Open Access
Anakinra treatment in multisystemic inflammatory syndrome in children (MIS-C) associated with COVID-19
20
Citations
15
References
2022
Year
Based on the results of the study, anakinra was associated with clinical improvements and was safe for most patients with refractory MIS-C.
| Year | Citations | |
|---|---|---|
Page 1
Page 1